SREBP2 downregulates ABCA1: A novel role of SREBP in regulating cholesterol metabolism

被引：0
|
作者：
Zhu, Y [1 ]
Zeng, LF [1 ]
Liao, HL [1 ]
Shyy, JY [1 ]
Stemerman, MB [1 ]
机构：
[1] Univ Calif Riverside, Riverside, CA 92521 USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1104
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [31] Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2
    Chen, Wen
    Wen, Liang
    Bao, Yingying
    Tang, Zengwei
    Zhao, Jianhui
    Zhang, Xiaozhen
    Wei, Tao
    Zhang, Jian
    Ma, Tao
    Zhang, Qi
    Zhi, Xiao
    Li, Jin
    Zhang, Cheng
    Ni, Lei
    Li, Muchun
    Liang, Tingbo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (52)
  • [32] The Role of Transporters ABCG1/4 and ABCA1 in Brain Cholesterol Metabolism
    Sun Hai-Mei
    Chen Li
    Mia Jin-Wei
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2014, 41 (08) : 765 - 776
  • [33] Genetic deletion of LDL receptor impairs mouse macrophage ABCA1 expression and cholesterol efflux: A new SREBP-1 dependent mechanism
    Han, Jihong
    He, Wei
    Zhou, Xiaoye
    Huang, Zhiping
    Nicholson, Andrew C.
    Gotto, Antonio M., Jr.
    Hajjar, David P.
    FASEB JOURNAL, 2007, 21 (05): : A16 - A16
  • [34] Gout-induced endothelial impairment: The role of SREBP2 transactivation of YAP
    Zhao, Zunlan
    Zhao, Yingshuai
    Zhang, Yuqing
    Shi, Weili
    Li, Xiqing
    Shyy, John Y. -J.
    He, Ming
    Wang, Liuyi
    FASEB JOURNAL, 2021, 35 (06):
  • [35] The Rorγ/SREBP2 Pathway Is a Master Regulator of Cholesterol Metabolism and Serves As Potential Therapeutic Target in T(4;11) Leukemia
    Erkner, Estelle
    Hentrich, Thomas
    Fitzel, Rahel
    Keppeler, Hildegard
    Korkmaz, Fulya
    Jeong, Johan
    Schulze-Hentrich, Julia
    Lengerke, Claudia
    Schneidawind, Dominik
    Schneidawind, Corina
    BLOOD, 2022, 140 : 2999 - 3000
  • [36] Cholesterol pathway determines ovarian cancer drug resistance through transcription factor SREBP2
    Karashchuk, Galina
    Karashchuk, Nataliya
    Caksa, Signe
    Smith, Tyler S.
    Brodsky, Alexander S.
    CANCER RESEARCH, 2017, 77
  • [37] COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
    Lee, Wonhwa
    Ahn, June Hong
    Park, Hee Ho
    Kim, Hong Nam
    Kim, Hyelim
    Yoo, Youngbum
    Shin, Hyosoo
    Hong, Kyung Soo
    Jang, Jong Geol
    Park, Chun Gwon
    Choi, Eun Young
    Bae, Jong-Sup
    Seo, Young-Kyo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [38] COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
    Wonhwa Lee
    June Hong Ahn
    Hee Ho Park
    Hong Nam Kim
    Hyelim Kim
    Youngbum Yoo
    Hyosoo Shin
    Kyung Soo Hong
    Jong Geol Jang
    Chun Gwon Park
    Eun Young Choi
    Jong-Sup Bae
    Young-Kyo Seo
    Signal Transduction and Targeted Therapy, 5
  • [39] TFCP2 Overcomes Senescence by Cooperating With SREBP2 to Activate Cholesterol Synthesis in Pancreatic Cancer
    Zhang, Dexiang
    Lu, Pinxiang
    Zhu, Kaihua
    Wu, Haixia
    Dai, Yuedi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] The RORγ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia
    Erkner, Estelle
    Hentrich, Thomas
    Schairer, Rebekka
    Fitzel, Rahel
    Secker-Grob, Kathy-Ann
    Jeong, Johan
    Keppeler, Hildegard
    Korkmaz, Fulya
    Schulze-Hentrich, Julia M.
    Lengerke, Claudia
    Schneidawind, Dominik
    Schneidawind, Corina
    ONCOGENE, 2024, 43 (04) : 281 - 293
12345